Label Image (Lbl500908002)
Letrozole Tablet
Product Images NDC 50090-8002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 50090-8002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Letrozole 01)
Figure 1 (Letrozole 02)
The text provides information on a comparison between Letrozole and Tamoxifen treatments based on the number of patients, events, and censoring rates over a period of 72 months. It includes data on the number of patients, events, censored cases, and treatment durations for both Letrozole and Tamoxifen. The study compares the effectiveness of these two treatments over 72 months.*
Figure 2 (Letrozole 03)
Progression-free months comparison of Letrozole tablets 2.5 mg and tamoxifen 20 mg for evaluation.*
Figure 3 (Letrozole 04)
Figure 4 (Letrozole 05)
This is a chart showing the time to progression in days for a treatment group using Letrozole Tablets 2.5 mg and Letrozole Tablets 0.5 mg. The chart displays data points ranging from 0.0 to 1000 for evaluation.*
Figure 5 (Letrozole 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
